Samit Shah
Interventional Cardiology · New Haven, CTNPI 1588939623
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (40.3%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Abbott accounts for 68.4% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $7,801, more than ten times the $115 reported in 2019.
Across 58 payments — averaging $331.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$13K
- Medtronic$3K
- Edwards Lifesciences$2K
- Shockwave Medical, Inc$1K
- Boston Scientific$390
- Philips North America LLC$369
- plus $68 from 2 others
Across 9 payments — averaging $62,730 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$540K
- Philips North America LLC$23K
- Shockwave Medical, Inc$2K
What the payments were for
- Consulting fees$7,75040%
- Speaking & faculty fees$2,87515%
- Travel & lodging$6,74035%
- Food & beverage$1,87910%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 22 | $13,166 |
| Medtronic(2 entities) | 7 | $2,679 |
| Edwards Lifesciences | 2 | $1,552 |
| Shockwave Medical, Inc | 2 | $1,021 |
| Boston Scientific | 17 | $390 |
| Philips North America LLC | 3 | $369 |
| Opsens Inc. | 3 | $52 |
| Cardiovascular Systems Inc. | 2 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COROFLOW$7,838
- Dragonfly OCT$2,750
- DRAGONFLY OPSTAR$1,999
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$1,000
- (9520) IGT Devices Undivided$369
- OPTIS$204
- CARDIOMEMS$138
How this compares
$19,244 in reported general payments places this provider in the 80th percentile of 73 interventional cardiology providers in Connecticut.
See all interventional cardiology providers in Connecticut →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Icosapent Ethyl | 12 | $1,224 |
| Verapamil ErVerapamil Hcl | 31 | $668 |
| Metoprolol Succinate | 23 | $402 |
| Nitroglycerin | 31 | $299 |
| Rosuvastatin Calcium | 11 | $159 |
| Carvedilol | 16 | $121 |
| Amlodipine Besylate | 11 | $11 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in New Haven
- Amit VoraNew Haven$409K
- Michael NannaNew Haven$60K
- Sameer NagpalNew Haven$43K
- Michael ChrissoherisNew Haven$24K
- Hari DeshpandeNew Haven$23K
- Yasin HussainNew Haven$13K
- Brad StairNew Haven$7K
- Chirag ShahNew Haven$5K
- Scott WillisNew Haven$4K
- Rabih TabetNew Haven$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.